Related Experiment Video
Updated: Jan 10, 2026

An Ex Vivo Tissue Culture Model of Cartilage Remodeling in Bovine Knee Explants
Published on: November 3, 2019
Inhibition of the proteasomal function in chondrocytes down-regulates growth plate chondrogenesis and longitudinal
Shufang Wu1, Francesco De Luca
1Section of Endocrinology and Diabetes, St. Christopher's Hospital for Children, Philadelphia, Pennsylvania 19134, USA.
Abstract:
The proteasome is a large multiprotein complex that processes intracellular proteins functioning as cell cycle regulators and transcription factors. It has been shown that the chymotryptic component of the proteasome is an important regulator of osteoblast differentiation and bone formation, with inhibitors of the proteasome increasing osteoblast differentiation and bone formation. Yet, little is known about the effects of the proteasomal activity in the growth plate. In the present study, we cultured rat metatarsal bones in the presence of proteasome inhibitor I (PSI), a known inhibitor of the chymotrypsin-like activity of the 20S proteasome. PSI suppressed growth plate chondrocyte proliferation and hypertrophy/differentiation, and induced chondrocyte apoptosis. All these cellular effects led to reduced metatarsal linear growth. In cultured chondrocytes, PSI increased the expression of beta-catenin (a negative regulator of chondrogenesis) and reduced the DNA binding of nuclear factor kappaB, a transcription factor that stimulates growth plate chondrogenesis. In conclusion, our findings suggest that the proteasomal activity facilitates growth plate chondrogenesis and, in turn, longitudinal bone growth.
Insights
Proteasome activity is crucial for growth plate chondrogenesis and longitudinal bone growth. Inhibiting the proteasome (PSI) suppressed chondrocyte proliferation and differentiation, hindering bone development.
Area of Science:
- Cell Biology
- Skeletal Biology
- Biochemistry
Background:
- The proteasome, a multiprotein complex, regulates intracellular proteins, including cell cycle regulators and transcription factors.
- Proteasome activity, particularly its chymotrypsin-like component, influences osteoblast differentiation and bone formation.
- The role of proteasomal activity within the growth plate remains largely unexplored.
Purpose of the Study:
- To investigate the impact of proteasome inhibition on growth plate chondrocytes and longitudinal bone growth.
- To elucidate the molecular mechanisms by which proteasomal activity affects chondrogenesis.
Main Methods:
- Cultured rat metatarsal bones in the presence of proteasome inhibitor I (PSI).
- Assessed chondrocyte proliferation, hypertrophy, differentiation, and apoptosis.
- Analyzed the expression of beta-catenin and the DNA binding of nuclear factor kappaB (NF-κB) in cultured chondrocytes.
Main Results:
- PSI significantly suppressed growth plate chondrocyte proliferation and hypertrophy/differentiation.
- PSI induced chondrocyte apoptosis, leading to reduced metatarsal linear growth.
- In chondrocytes, PSI increased beta-catenin expression and decreased NF-κB DNA binding.
Conclusions:
- Proteasomal activity is essential for facilitating growth plate chondrogenesis.
- Inhibition of proteasomal activity negatively impacts longitudinal bone growth by disrupting chondrogenesis.
- These findings highlight the proteasome as a potential target for modulating bone growth.
Related Concept Videos
Bone Formation by Endochondral Ossification
Growth of Cartilage and Bone Tissue
TGF - β Signaling Pathway
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

